HGH is an endogenous peptide hormone of the pituitary gland, consisting of 191 amino acids, with a molecular mass of 22.1 kDa, and belonging to the class of somatotropic hormones. Recombinantly produced HGH — scientifically referred to as somatropin — is structurally identical to the body's own growth hormone and is produced using recombinant DNA technology in prokaryotic or eukaryotic expression systems.
Mechanism of Action and Pharmacology
Somatropin binds to the transmembrane GH receptor (GHR), a type I cytokine receptor, and induces its homodimerization. This conformational change activates the receptor-associated Janus kinase 2 (JAK2), which subsequently phosphorylates STAT5b. Phosphorylated STAT5b translocates into the cell nucleus and regulates the transcription of target genes, including IGF-1, which is synthesized in the liver and released into the bloodstream. The subcutaneous bioavailability of somatropin is approximately 80%; the plasma half-life following subcutaneous injection is 3–5 hours, while the biological effect mediated via the secondary IGF-1 increase persists for up to 12–18 hours. In addition to the IGF-1-dependent growth signal, GH exerts direct effects on fat cells: it activates hormone-sensitive lipase and mobilizes free fatty acids from triglyceride stores. GH also promotes nitrogen retention and supports protein synthesis in skeletal muscle cells via the PI3K/Akt/mTOR signaling pathway.
Quality control standards for pharmaceutical somatropin include reversed-phase HPLC for purity determination (requirement: main peak ≥ 95% per Ph. Eur.) as well as mass spectrometry to confirm the correct primary structure. Pyrogenicity testing is carried out via endotoxin assays according to Ph. Eur. 2.6.14.
Application Context
Somatropin has medical applications in growth hormone deficiency in children and adults, Turner syndrome, chronic renal insufficiency, and HIV-associated lipodystrophy. Outside of approved indications, the substance is used in athletic contexts, with dosage ranges and protocol design depending on individual goals — muscle building, body composition, or tissue regeneration.
Relevant side effects include fluid retention with peripheral edema, arthralgias, myalgias, and a dose-dependent reduction in peripheral insulin sensitivity. Regular monitoring of fasting glucose levels is medically indicated at dosages of 4 IU per day or higher.
Range & Selection
The current range comprises 13 products from manufacturers including Pfizer, Novo Nordisk, Lilly, and various specialized laboratories. Concentrations range from 8 IU per vial to 72 IU per vial, with package sizes from a single vial to sets of 25 vials.
Pharmaceutical originator products such as Genotropin 36 IU (Pfizer) and Norditropin 45 IU (Novo Nordisk) are subject to full EMA approval procedures including Phase III studies and post-marketing surveillance. They are primarily suited for medically indicated therapies where batch documentation and product integrity must meet regulatory requirements. Humatrope 72 IU (Lilly), offering the highest single-vial concentration in the range, provides an option for protocols with higher weekly requirements and reduced reconstitution intervals.
Generic somatropin preparations such as Hygetropin (Hygene) or Jintropin (Gensci) are available in multi-vial sets (e.g., 10 × 10 IU or 10 × 12 IU) and allow flexible portioning of weekly requirements. They are aimed at users who wish to stock larger quantities and prefer handling smaller individual doses. Liquid formulations such as Liquid 50 IU (Imperia Laboratories) eliminate the reconstitution step but require an uninterrupted cold chain, as protein stability in aqueous solution is lower than in the lyophilized state.
Frequently Asked Questions
What is HGH and which substance class does it belong to?
HGH (Human Growth Hormone), scientifically known as somatropin, is an endogenous peptide hormone of the anterior pituitary gland with a chain length of 191 amino acids and a molecular mass of 22.1 kDa. It belongs to the class of somatotropic hormones and is produced recombinantly to reproduce the identical primary structure of the body's own hormone. Recombinant somatropin has been the gold standard of growth hormone replacement therapy since the 1980s.
How does somatropin work at the molecular level?
Somatropin binds to the GH receptor and induces its homodimerization, which activates JAK2 and stimulates hepatic IGF-1 production via STAT5b phosphorylation. GH also acts directly in a lipolytic manner on adipocytes and promotes protein synthesis in muscle cells. The plasma half-life following subcutaneous administration is 3–5 hours; the biological effect mediated via IGF-1 persists considerably longer.
What is the difference between pharmaceutical originators such as Genotropin and generic HGH preparations?
Pharmaceutical originators such as Genotropin (Pfizer) or Norditropin (Novo Nordisk) undergo complete approval procedures to EMA standards, including controlled clinical studies, standardized batch analytics, and a secured cold chain. Generic preparations such as Hygetropin or Jintropin often offer larger package sizes at varying concentrations without equivalent regulatory documentation; purity testing by HPLC is more difficult for users to verify independently with these products.
Customer Favorite
